loader
Please Wait
Applying Filters...
menu
    • menu

    Drug Product Composition: Tazarotene

    Client Email Product
    Menu

    Tazarotene

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 16,511Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 21184 / DOSAGE - CREAM;TOPICAL - 0.1%

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    tazarotene(UNII: 81BDR9Y8PS)
    (tazarotene - UNII:81BDR9Y8PS)     		tazarotene1mg in 1 | 0.5mg in 1

    Inactive Ingredients

    Ingredient Name
    Allergan, Inc.
    E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.
    benzyl alcohol(LKG8494WBH)
    CAPRYLIC/CAPRIC MONO/DI-GLYCERIDES(U72Q2I8C85) 
    carbomer 1342(809Y72KV36) 
    CARBOMER COPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED)(809Y72KV36) 
    carbomer homopolymer type B (allyl pentaerythritol crosslinked)(HHT01ZNK31)
    edetate disodium(7FLD91C86K)
    GLYCERYL CAPRYLOCAPRATE(U72Q2I8C85) 
    MEDIUM-CHAIN TRIGLYCERIDES(C9H2L21V7U) 
    mineral oil(T5L8T28FGP)
    sodium hydroxide(55X04QC32I)
    sodium thiosulfate(HX1032V43M)
    sorbitan monooleate(06XEA2VD56)
    water(059QF0KO0R)